Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy

A. Coppola; A. D'Ausilio; A. Aiello; S. Amoresano; M. Toumi; P. Mathew; A. Tagliaferri; the Potter Study Group; G. Feola; A.C. Molinari; C. Santoro; G.F. Rivolta; D.B. Cultrera; F. Gagliano; E. Zanon; M.E. Mancuso; L. Valdrè; L. Mameli; L. Banov; G. Di Minno; G. Quintavalle; M.G. Mazzucconi; N. Negri; E. Santagostino

doi:10.1111/hae.13185

Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy

A. Coppola, A. D'Ausilio, A. Aiello, S. Amoresano, M. Toumi, P. Mathew, A. Tagliaferri, the Potter Study Group, G. Feola, A.C. Molinari, C. Santoro, G.F. Rivolta, D.B. Cultrera, F. Gagliano, E. Zanon, M.E. Mancuso, L. Valdrè, L. Mameli, L. Banov, G. Di MinnoG. Quintavalle, M.G. Mazzucconi, N. Negri, E. Santagostino

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	422-429
Number of pages	8
Journal	Haemophilia
Volume	23
Issue number	3
DOIs	https://doi.org/10.1111/hae.13185
Publication status	Published - 2017

Keywords

recombinant blood clotting factor 8
blood clotting factor 8, adolescent
adult
Article
clinical outcome
controlled study
cost effectiveness analysis
disease severity
health status
hemophilia A
human
Italy
late prophylaxis
on demand therapy
patient compliance
priority journal
prophylaxis
quality adjusted life year
sensitivity analysis
therapy
cost benefit analysis
economics
Markov chain
quality of life, Cost-Benefit Analysis
Factor VIII
Hemophilia A
Humans
Markov Chains
Quality of Life

Access to Document

10.1111/hae.13185

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85012880895&doi=10.1111%2fhae.13185&partnerID=40&md5=61e7a1cf0a7c25e2396d9c741ef57919

Cite this

Coppola, A., D'Ausilio, A., Aiello, A., Amoresano, S., Toumi, M., Mathew, P., Tagliaferri, A., Group, T. P. S., Feola, G., Molinari, A. C., Santoro, C., Rivolta, G. F., Cultrera, D. B., Gagliano, F., Zanon, E., Mancuso, M. E., Valdrè, L., Mameli, L., Banov, L., ... Santagostino, E. (2017). Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy. Haemophilia, 23(3), 422-429. https://doi.org/10.1111/hae.13185

Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy. / Coppola, A.; D'Ausilio, A.; Aiello, A.; Amoresano, S.; Toumi, M.; Mathew, P.; Tagliaferri, A.; Group, the Potter Study; Feola, G.; Molinari, A.C.; Santoro, C.; Rivolta, G.F.; Cultrera, D.B.; Gagliano, F.; Zanon, E.; Mancuso, M.E.; Valdrè, L.; Mameli, L.; Banov, L.; Di Minno, G.; Quintavalle, G.; Mazzucconi, M.G.; Negri, N.; Santagostino, E.

In: Haemophilia, Vol. 23, No. 3, 2017, p. 422-429.

Research output: Contribution to journal › Article › peer-review

Coppola, A, D'Ausilio, A, Aiello, A, Amoresano, S, Toumi, M, Mathew, P, Tagliaferri, A, Group, TPS, Feola, G, Molinari, AC, Santoro, C, Rivolta, GF, Cultrera, DB, Gagliano, F, Zanon, E, Mancuso, ME, Valdrè, L, Mameli, L, Banov, L, Di Minno, G, Quintavalle, G, Mazzucconi, MG, Negri, N & Santagostino, E 2017, 'Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy', Haemophilia, vol. 23, no. 3, pp. 422-429. https://doi.org/10.1111/hae.13185

Coppola, A. ; D'Ausilio, A. ; Aiello, A. ; Amoresano, S. ; Toumi, M. ; Mathew, P. ; Tagliaferri, A. ; Group, the Potter Study ; Feola, G. ; Molinari, A.C. ; Santoro, C. ; Rivolta, G.F. ; Cultrera, D.B. ; Gagliano, F. ; Zanon, E. ; Mancuso, M.E. ; Valdrè, L. ; Mameli, L. ; Banov, L. ; Di Minno, G. ; Quintavalle, G. ; Mazzucconi, M.G. ; Negri, N. ; Santagostino, E. / Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy. In: Haemophilia. 2017 ; Vol. 23, No. 3. pp. 422-429.

@article{c02487216d3248848b6c1ccf8fc5a641,

title = "Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy",

keywords = "recombinant blood clotting factor 8, blood clotting factor 8, adolescent, adult, Article, clinical outcome, controlled study, cost effectiveness analysis, disease severity, health status, hemophilia A, human, Italy, late prophylaxis, on demand therapy, patient compliance, priority journal, prophylaxis, quality adjusted life year, sensitivity analysis, therapy, cost benefit analysis, economics, Markov chain, quality of life, Cost-Benefit Analysis, Factor VIII, Hemophilia A, Humans, Markov Chains, Quality of Life",

author = "A. Coppola and A. D'Ausilio and A. Aiello and S. Amoresano and M. Toumi and P. Mathew and A. Tagliaferri and Group, {the Potter Study} and G. Feola and A.C. Molinari and C. Santoro and G.F. Rivolta and D.B. Cultrera and F. Gagliano and E. Zanon and M.E. Mancuso and L. Valdr{\`e} and L. Mameli and L. Banov and {Di Minno}, G. and G. Quintavalle and M.G. Mazzucconi and N. Negri and E. Santagostino",

year = "2017",

doi = "10.1111/hae.13185",

language = "English",

volume = "23",

pages = "422--429",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy

AU - Coppola, A.

AU - D'Ausilio, A.

AU - Aiello, A.

AU - Amoresano, S.

AU - Toumi, M.

AU - Mathew, P.

AU - Tagliaferri, A.

AU - Group, the Potter Study

AU - Feola, G.

AU - Molinari, A.C.

AU - Santoro, C.

AU - Rivolta, G.F.

AU - Cultrera, D.B.

AU - Gagliano, F.

AU - Zanon, E.

AU - Mancuso, M.E.

AU - Valdrè, L.

AU - Mameli, L.

AU - Banov, L.

AU - Di Minno, G.

AU - Quintavalle, G.

AU - Mazzucconi, M.G.

AU - Negri, N.

AU - Santagostino, E.

PY - 2017

Y1 - 2017

KW - recombinant blood clotting factor 8

KW - blood clotting factor 8, adolescent

KW - adult

KW - Article

KW - clinical outcome

KW - controlled study

KW - cost effectiveness analysis

KW - disease severity

KW - health status

KW - hemophilia A

KW - human

KW - Italy

KW - late prophylaxis

KW - on demand therapy

KW - patient compliance

KW - priority journal

KW - prophylaxis

KW - quality adjusted life year

KW - sensitivity analysis

KW - therapy

KW - cost benefit analysis

KW - economics

KW - Markov chain

KW - quality of life, Cost-Benefit Analysis

KW - Factor VIII

KW - Hemophilia A

KW - Humans

KW - Markov Chains

KW - Quality of Life

U2 - 10.1111/hae.13185

DO - 10.1111/hae.13185

M3 - Article

VL - 23

SP - 422

EP - 429

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 3

ER -